FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022061576> ?p ?o ?g. }

• W2022061576 endingPage "110" @default.
• W2022061576 startingPage "105" @default.
• W2022061576 abstract "Rofecoxib is a specific COX-2 inhibitor able to exert antiproliferative activity against colorectal cancer cells. It was withdrawn from the market after the demonstration of an increased risk of cardiovascular complications after prolonged use. Nevertheless, it remains an interesting compound for laboratory research as an experimental COX-2 inhibitor. In this study, the antiproliferative activity of a novel dinitro-oxy-substituted analogue of rofecoxib (NO-rofe), potentially less cardiotoxic, has been investigated in vitro on human colon cancer cells and compared with the action of the parent drug. Due to the fact that COX-2 inhibition is the main characteristic of coxibs, we performed all experiments in COX-2-overexpressing (HT-29) and COX-2-negative (SW-480) human colon cancer cells, to elucidate whether the observed effects were dependent on COX-2 inhibition. Moreover, experiments were performed in order to evaluate whether COX-2 pharmacological inhibition may affect beta-catenin/E-cadherin signaling pathway. NO-rofe exerted a significant antiproliferative activity on COX-2 positive HT-29 human colon cancer cells, being less effective on the COX-2 negative SW-480 human colon cancer cell line. In particular, the rofecoxib analogue retained similar potencies with respect to COX-2 inhibition but was much more active than rofecoxib in inhibiting the growth of human colon cancer cells in vitro. In addition, this novel compound resulted in the induction of membrane β-catenin/E-cadherin expression, a feature that may significantly contribute to its antiproliferative activity." @default.
• W2022061576 created "2016-06-24" @default.
• W2022061576 creator A5040501332 @default.
• W2022061576 creator A5050608798 @default.
• W2022061576 creator A5065678199 @default.
• W2022061576 creator A5073906610 @default.
• W2022061576 date "2011-10-15" @default.
• W2022061576 modified "2023-09-24" @default.
• W2022061576 title "A novel nitro-oxy substituted analogue of rofecoxib reduces human colon cancer cell growth" @default.
• W2022061576 cites W140965324 @default.
• W2022061576 cites W1965472905 @default.
• W2022061576 cites W1967447048 @default.
• W2022061576 cites W1967532587 @default.
• W2022061576 cites W1974081986 @default.
• W2022061576 cites W1982248155 @default.
• W2022061576 cites W1986160028 @default.
• W2022061576 cites W2004572576 @default.
• W2022061576 cites W2030488396 @default.
• W2022061576 cites W2032038709 @default.
• W2022061576 cites W2040373623 @default.
• W2022061576 cites W2053854129 @default.
• W2022061576 cites W2069355129 @default.
• W2022061576 cites W2096214657 @default.
• W2022061576 cites W2096874183 @default.
• W2022061576 cites W2117784691 @default.
• W2022061576 cites W2124990759 @default.
• W2022061576 cites W2125471714 @default.
• W2022061576 cites W2134234269 @default.
• W2022061576 cites W2148558073 @default.
• W2022061576 cites W2152064969 @default.
• W2022061576 cites W2158968701 @default.
• W2022061576 cites W2330496155 @default.
• W2022061576 doi "https://doi.org/10.1007/s11010-011-1094-9" @default.
• W2022061576 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22002318" @default.
• W2022061576 hasPublicationYear "2011" @default.
• W2022061576 type Work @default.
• W2022061576 sameAs 2022061576 @default.
• W2022061576 citedByCount "2" @default.
• W2022061576 countsByYear W20220615762016 @default.
• W2022061576 countsByYear W20220615762020 @default.
• W2022061576 crossrefType "journal-article" @default.
• W2022061576 hasAuthorship W2022061576A5040501332 @default.
• W2022061576 hasAuthorship W2022061576A5050608798 @default.
• W2022061576 hasAuthorship W2022061576A5065678199 @default.
• W2022061576 hasAuthorship W2022061576A5073906610 @default.
• W2022061576 hasBestOaLocation W20220615762 @default.
• W2022061576 hasConcept C121608353 @default.
• W2022061576 hasConcept C126322002 @default.
• W2022061576 hasConcept C181199279 @default.
• W2022061576 hasConcept C185592680 @default.
• W2022061576 hasConcept C2778582115 @default.
• W2022061576 hasConcept C2779689624 @default.
• W2022061576 hasConcept C502942594 @default.
• W2022061576 hasConcept C526805850 @default.
• W2022061576 hasConcept C54355233 @default.
• W2022061576 hasConcept C55493867 @default.
• W2022061576 hasConcept C62112901 @default.
• W2022061576 hasConcept C71924100 @default.
• W2022061576 hasConcept C81885089 @default.
• W2022061576 hasConcept C86803240 @default.
• W2022061576 hasConcept C96232424 @default.
• W2022061576 hasConcept C98274493 @default.
• W2022061576 hasConceptScore W2022061576C121608353 @default.
• W2022061576 hasConceptScore W2022061576C126322002 @default.
• W2022061576 hasConceptScore W2022061576C181199279 @default.
• W2022061576 hasConceptScore W2022061576C185592680 @default.
• W2022061576 hasConceptScore W2022061576C2778582115 @default.
• W2022061576 hasConceptScore W2022061576C2779689624 @default.
• W2022061576 hasConceptScore W2022061576C502942594 @default.
• W2022061576 hasConceptScore W2022061576C526805850 @default.
• W2022061576 hasConceptScore W2022061576C54355233 @default.
• W2022061576 hasConceptScore W2022061576C55493867 @default.
• W2022061576 hasConceptScore W2022061576C62112901 @default.
• W2022061576 hasConceptScore W2022061576C71924100 @default.
• W2022061576 hasConceptScore W2022061576C81885089 @default.
• W2022061576 hasConceptScore W2022061576C86803240 @default.
• W2022061576 hasConceptScore W2022061576C96232424 @default.
• W2022061576 hasConceptScore W2022061576C98274493 @default.
• W2022061576 hasIssue "1-2" @default.
• W2022061576 hasLocation W20220615761 @default.
• W2022061576 hasLocation W20220615762 @default.
• W2022061576 hasLocation W20220615763 @default.
• W2022061576 hasOpenAccess W2022061576 @default.
• W2022061576 hasPrimaryLocation W20220615761 @default.
• W2022061576 hasRelatedWork W1968439879 @default.
• W2022061576 hasRelatedWork W1976460300 @default.
• W2022061576 hasRelatedWork W1981662925 @default.
• W2022061576 hasRelatedWork W1990756964 @default.
• W2022061576 hasRelatedWork W2026092514 @default.
• W2022061576 hasRelatedWork W2049255613 @default.
• W2022061576 hasRelatedWork W2052159235 @default.
• W2022061576 hasRelatedWork W2053833211 @default.
• W2022061576 hasRelatedWork W2091814299 @default.
• W2022061576 hasRelatedWork W4291014994 @default.
• W2022061576 hasVolume "361" @default.
• W2022061576 isParatext "false" @default.
• W2022061576 isRetracted "false" @default.
• W2022061576 magId "2022061576" @default.

• next